MetaADEDB 2.0 @ LMMD
Valacyclovir
(HDOVUKNUBWVHOX-QMMMGPOBSA-N)
Structure
SMILES
CC([C@@H](C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O)N)C
Type(s)
Approved; Investigational
ATC code(s)
J05AB11
Molecular Formula:
C13H20N6O4
Molecular Weight:
324.336
Log P:
0.4839
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
3
TPSA:
151.14
CAS Number(s):
124832-26-4
Synonym(s)
1.
Valacyclovir
2.
2-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl L-valinate
3.
256U87
4.
Acyclovir, L-valyl Ester
5.
BW256U87
6.
L-Valylacyclovir
7.
Valaciclovir
8.
Valacyclovir Hydrochloride
9.
Valacyclovir Hydrochloride, (DL)-isomer
10.
Valacyclovir, (D)-isomer
11.
Valacyclovir, (DL)-isomer
12.
Valacyclovir, (L)-isomer
13.
Valacyclovir, D-
14.
Valacyclovir, X-Hydrochloride, (D)-isomer
15.
Valacyclovir, X-Hydrochloride, (DL)-isomer
16.
Valtrex
17.
Acyclovir, L valyl Ester
18.
D- Valacyclovir
19.
L Valylacyclovir
20.
L-valyl Ester Acyclovir
External Link(s)
MeSHD000077483
PubChem Compound135398742
60773
BindingDB50162073
ChEBI35854
CHEMBLCHEMBL1349
DrugBankDB00577
DrugCentral2798
IUPHAR/BPS Guide to PHARMACOLOGY4824
KEGGcpd:C07184
dr:D00398
dr:D08664
Therapeutic Target DatabaseD04QJD
ZINC1530713
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 627
Canada Vigilance: 24
Canada Vigilance
US FAERS
2DizzinessFAERS: 175
Canada Vigilance: 18
Canada Vigilance
OFFSIDES
US FAERS
3Altered state of consciousnessFAERS: 172OFFSIDES
US FAERS
4HeadacheFAERS: 172
Canada Vigilance: 14
11197578
14632597
CTD
Canada Vigilance
US FAERS
5NauseaFAERS: 172
Canada Vigilance: 15
Canada Vigilance
OFFSIDES
US FAERS
6OverdoseFAERS: 121OFFSIDES
US FAERS
7DysarthriaFAERS: 105
Canada Vigilance: 3
Canada Vigilance
US FAERS
8VomitingFAERS: 104
Canada Vigilance: 14
Canada Vigilance
US FAERS
9Depressed Level of ConsciousnessFAERS: 101OFFSIDES
US FAERS
10MalaiseFAERS: 100
Canada Vigilance: 3
Canada Vigilance
US FAERS
11nervous system disorderFAERS: 94
Canada Vigilance: 1
Canada Vigilance
US FAERS
12DeliriumFAERS: 84
Canada Vigilance: 3
Canada Vigilance
US FAERS
13Drug exposure during pregnancyFAERS: 76US FAERS
14Product substitution issueFAERS: 72
Canada Vigilance: 6
Canada Vigilance
US FAERS
15Blood creatinine increasedFAERS: 70OFFSIDES
US FAERS
16PruritusFAERS: 70
Canada Vigilance: 4
Canada Vigilance
US FAERS
17Acute kidney injuryFAERS: 62
Canada Vigilance: 1

View details

CTD
Canada Vigilance
US FAERS
18PainFAERS: 62
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
19DisorientationFAERS: 61US FAERS
20Feeling abnormalFAERS: 56
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
21RestlessnessFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Therapeutic response unexpectedFAERS: 54US FAERS
23FatigueFAERS: 50
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
US FAERS
24SomnolenceFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
25AstheniaFAERS: 48
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
26UrticariaFAERS: 46
Canada Vigilance: 3
Canada Vigilance
US FAERS
27HypersensitivityFAERS: 44
Canada Vigilance: 2
Canada Vigilance
US FAERS
28Abdominal PainFAERS: 43
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
29Blood urea increasedFAERS: 40OFFSIDES
US FAERS
30Adverse eventFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
31Back PainFAERS: 38
Canada Vigilance: 5
Canada Vigilance
US FAERS
32Toxicity to various agentsFAERS: 38US FAERS
33Abdominal discomfortFAERS: 37
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
34Psychiatric symptomFAERS: 37OFFSIDES
US FAERS
35DyslaliaFAERS: 34OFFSIDES
US FAERS
36AgitationFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
37AlopeciaFAERS: 32
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
38Drug administration errorFAERS: 30US FAERS
39ArthralgiaFAERS: 29
Canada Vigilance: 5
Canada Vigilance
US FAERS
40TremorFAERS: 29
Canada Vigilance: 5
Canada Vigilance
US FAERS
41Product quality issueFAERS: 28US FAERS
42DehydrationFAERS: 25
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
43AnxietyFAERS: 23
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
44Prescribed overdoseFAERS: 23US FAERS
45AnorexiaFAERS: 22OFFSIDES
US FAERS
46Genital HerpesFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
47Drug toxicityFAERS: 21US FAERS
48Pathogen resistanceFAERS: 21US FAERS
49ErythemaFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
50Burning sensationFAERS: 18OFFSIDES
US FAERS
51Urinary RetentionFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
52DysuriaFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
53Incorrect dose administeredFAERS: 17US FAERS
54PneumoniaFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
55VertigoFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
56Erythema MultiformeFAERS: 16US FAERS
57Mental status changesFAERS: 16OFFSIDES
US FAERS
58MyalgiaFAERS: 16US FAERS
59PalpitationsFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
60White blood cell count decreasedFAERS: 16US FAERS
61Aspartate Aminotransferase IncreasedFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
62Medication ErrorFAERS: 15
Canada Vigilance: 3
Canada Vigilance
US FAERS
63Accidental overdoseFAERS: 14US FAERS
64Cerebrovascular accidentFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
65ChillsFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
66Drug resistanceFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
67DysgeusiaFAERS: 14OFFSIDES
US FAERS
68NasopharyngitisFAERS: 14US FAERS
69Oropharyngeal painFAERS: 14OFFSIDES
US FAERS
70PancytopeniaFAERS: 14US FAERS
71Visual ImpairmentFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
72Chest discomfortFAERS: 13
Canada Vigilance: 4
Canada Vigilance
US FAERS
73ConstipationFAERS: 13US FAERS
74Lip swellingFAERS: 13US FAERS
75Alanine Aminotransferase IncreasedFAERS: 12
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
76AnuriaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
77Blood potassium increasedFAERS: 12OFFSIDES
US FAERS
78MyoclonusFAERS: 12US FAERS
79SwellingFAERS: 12US FAERS
80AphasiaFAERS: 11US FAERS
81DeafnessFAERS: 11OFFSIDES
US FAERS
82EczemaFAERS: 11US FAERS
83Eye painFAERS: 11US FAERS
84Skin lesionFAERS: 11OFFSIDES
US FAERS
85Cerebral InfarctionFAERS: 10US FAERS
86ChromaturiaFAERS: 10OFFSIDES
US FAERS
87Cotard's syndromeFAERS: 10US FAERS
88Disease recurrenceFAERS: 10OFFSIDES
US FAERS
89Drug dose omissionFAERS: 10US FAERS
90Mental impairmentFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
91Musculoskeletal stiffnessFAERS: 10OFFSIDES
US FAERS
92NephrolithiasisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
93Pharmaceutical product complaintFAERS: 10US FAERS
94Product use in unapproved indicationFAERS: 10US FAERS
95Product use issueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Stevens-Johnson SyndromeFAERS: 10US FAERS
97ChokingFAERS: 9US FAERS
98DyspepsiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
99InfectionFAERS: 9OFFSIDES
US FAERS
100MeningitisFAERS: 9US FAERS
101Metabolic acidosisFAERS: 9OFFSIDES
US FAERS
102OliguriaFAERS: 9OFFSIDES
US FAERS
103Rash erythematousFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
104Weight decreasedFAERS: 9US FAERS
105Wrong technique in product usage processFAERS: 9US FAERS
106AcneFAERS: 8OFFSIDES
US FAERS
107AmnesiaFAERS: 8OFFSIDES
US FAERS
108BlindnessFAERS: 8US FAERS
109Chest PainFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
110Depressed moodFAERS: 8US FAERS
111HypotensionFAERS: 8US FAERS
112Limb injuryFAERS: 8OFFSIDES
US FAERS
113Memory impairmentFAERS: 8US FAERS
114ThrombocytopeniaFAERS: 8US FAERS
115Anaphylactoid ReactionFAERS: 7US FAERS
116AtaxiaFAERS: 718156240CTD
OFFSIDES
US FAERS
117Bone painFAERS: 7US FAERS
118CheilitisFAERS: 7US FAERS
119DiscomfortFAERS: 7US FAERS
120Drug prescribing errorFAERS: 7US FAERS
121Emotional distressFAERS: 7OFFSIDES
US FAERS
122Inappropriate schedule of drug administrationFAERS: 7US FAERS
123IncoherentFAERS: 7OFFSIDES
US FAERS
124Intentional product misuseFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Joint swellingFAERS: 7US FAERS
126LethargyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
127LeukopeniaFAERS: 7US FAERS
128Neck PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
129NeutropeniaFAERS: 7US FAERS
130Pharyngolaryngeal PainFAERS: 7OFFSIDES
US FAERS
131StomatitisFAERS: 7US FAERS
132SyncopeFAERS: 7US FAERS
133Viral load increasedFAERS: 7US FAERS
134AbasiaFAERS: 6OFFSIDES
US FAERS
135Accidental exposureFAERS: 6US FAERS
136AngioedemaFAERS: 6US FAERS
137CryingFAERS: 6
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
138DementiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
139DiverticulitisFAERS: 6US FAERS
140FibromyalgiaFAERS: 6OFFSIDES
US FAERS
141InflammationFAERS: 6US FAERS
142Intentional product use issueFAERS: 6US FAERS
143Maternal exposure during pregnancyFAERS: 6US FAERS
144Respiratory distressFAERS: 6US FAERS
145RetchingFAERS: 6US FAERS
146ShockFAERS: 6US FAERS
147StressFAERS: 6US FAERS
148TachycardiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Toxic Epidermal NecrolysisFAERS: 6US FAERS
150Unevaluable eventFAERS: 6US FAERS
151jaundiceFAERS: 6US FAERS
152AcidosisFAERS: 5OFFSIDES
US FAERS
153Acquired gene mutationFAERS: 5US FAERS
154AgranulocytosisFAERS: 5US FAERS
155AngerFAERS: 5US FAERS
156Atrial FibrillationFAERS: 5US FAERS
157Blood lactate dehydrogenase increasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
158Blood urine presentFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
159Central nervous system lesionFAERS: 5OFFSIDES
US FAERS
160Diabetes InsipidusFAERS: 5US FAERS
161Disease ProgressionFAERS: 5US FAERS
162Drug dispensing errorFAERS: 5US FAERS
163Drug effect incompleteFAERS: 5US FAERS
164Drug exposure via breast milkFAERS: 5US FAERS
165Dry skinFAERS: 5US FAERS
166DyscalculiaFAERS: 5US FAERS
167EncephalitisFAERS: 5OFFSIDES
US FAERS
168EpistaxisFAERS: 5US FAERS
169Expired drug administeredFAERS: 5US FAERS
170GastritisFAERS: 5US FAERS
171HepatitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
172HypersomniaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
173Impaired driving abilityFAERS: 5US FAERS
174Impaired work abilityFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Incorrect product administration durationFAERS: 5US FAERS
176Live BirthFAERS: 5US FAERS
177Medication residueFAERS: 5US FAERS
178Musculoskeletal PainFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
179Nonspecific reactionFAERS: 5US FAERS
180Oral painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Posterior reversible encephalopathy syndromeFAERS: 5US FAERS
182PresyncopeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
183PurpuraFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
184Renal painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
185RhabdomyolysisFAERS: 5US FAERS
186ScreamingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
187SepsisFAERS: 5US FAERS
188AppendicitisFAERS: 4US FAERS
189AscitesFAERS: 4OFFSIDES
US FAERS
190Blood alkaline phosphatase increasedFAERS: 4
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
191ClumsinessFAERS: 4US FAERS
192Drug ineffective for unapproved indicationFAERS: 4US FAERS
193Drug level increasedFAERS: 4US FAERS
194DysphoniaFAERS: 4OFFSIDES
US FAERS
195Emergency care examinationFAERS: 4US FAERS
196FlatulenceFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
197General physical health deteriorationFAERS: 4OFFSIDES
US FAERS
198Genital painFAERS: 4US FAERS
199HepatomegalyFAERS: 4US FAERS
200MacrocytosisFAERS: 4US FAERS
201NervousnessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
202NeuralgiaFAERS: 416682531CTD
US FAERS
203No adverse eventFAERS: 4US FAERS
204Poor quality sleepFAERS: 4US FAERS
205PoriomaniaFAERS: 4US FAERS
206Respiratory DepressionFAERS: 4US FAERS
207Sjogren's SyndromeFAERS: 4US FAERS
208Status EpilepticusFAERS: 4US FAERS
209ThrombosisFAERS: 4US FAERS
210TinnitusFAERS: 4US FAERS
211UveitisFAERS: 4US FAERS
212skin abrasionFAERS: 4US FAERS
213treatment failureFAERS: 4US FAERS
214Acute zonal occult outer retinopathyFAERS: 3US FAERS
215Aphthous StomatitisFAERS: 3OFFSIDES
US FAERS
216Blood creatine increasedFAERS: 3US FAERS
217Blood triglycerides increasedFAERS: 3OFFSIDES
US FAERS
218BradycardiaFAERS: 3US FAERS
219Cerebral calcificationFAERS: 3US FAERS
220Completed SuicideFAERS: 3US FAERS
221Creatinine renal clearance decreasedFAERS: 3US FAERS
222Deep Vein ThrombosisFAERS: 3US FAERS
223DiplopiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
224DisabilityFAERS: 3US FAERS
225Disseminated Intravascular CoagulationFAERS: 3US FAERS
226DysphasiaFAERS: 3US FAERS
227Eating disorder symptomFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
228EpilepsyFAERS: 3US FAERS
229Euphoric moodFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
230Expired product administeredFAERS: 3US FAERS
231Extra dose administeredFAERS: 3US FAERS
232Gamma-Glutamyltransferase IncreasedFAERS: 3
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
233Gastrointestinal PainFAERS: 3US FAERS
234Herpes Zoster OticusFAERS: 3US FAERS
235HypophagiaFAERS: 3OFFSIDES
US FAERS
236HyporeflexiaFAERS: 3US FAERS
237Joint stiffnessFAERS: 3OFFSIDES
US FAERS
238Leukocytoclastic vasculitisFAERS: 3US FAERS
239LymphadenopathyFAERS: 3US FAERS
240Meningeal disorderFAERS: 3US FAERS
241Micturition frequency decreasedFAERS: 3US FAERS
242Mood swingsFAERS: 3US FAERS
243Neutropenic colitisFAERS: 3US FAERS
244Oculomucocutaneous syndromeFAERS: 3US FAERS
245PallorFAERS: 3US FAERS
246PancreatitisFAERS: 3US FAERS
247ParanoiaFAERS: 3US FAERS
248Peripheral swellingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
249Peritoneal DialysisFAERS: 3US FAERS
250Post-traumatic neck syndromeFAERS: 3US FAERS
251Renal tubular disorderFAERS: 3US FAERS
252Renal tubular necrosisFAERS: 3US FAERS
253Skin ErosionFAERS: 3US FAERS
254Skin reactionFAERS: 3US FAERS
255SnoringFAERS: 3US FAERS
256SoliloquyFAERS: 3US FAERS
257Therapeutic response delayedFAERS: 3US FAERS
258ThirstFAERS: 3US FAERS
259Unresponsive to stimuliFAERS: 3US FAERS
260Urinary tract infectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
261VIIth nerve paralysisFAERS: 3US FAERS
262Vaginal DischargeFAERS: 3US FAERS
263Vaginal lesionFAERS: 3US FAERS
264VasculitisFAERS: 3
Canada Vigilance: 1
15159513CTD
Canada Vigilance
US FAERS
265Vulvovaginal pruritusFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
266WheezingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
267effusionFAERS: 3OFFSIDES
US FAERS
268AkinesiaFAERS: 2US FAERS
269Ankle FractureFAERS: 2US FAERS
270AsterixisFAERS: 2OFFSIDES
US FAERS
271AsthmaFAERS: 2US FAERS
272Autoimmune hepatitisFAERS: 2US FAERS
273Benign Prostatic HyperplasiaFAERS: 2US FAERS
274Birth markFAERS: 2US FAERS
275Bladder painFAERS: 2US FAERS
276BlepharitisFAERS: 2US FAERS
277Blood amylase increasedFAERS: 2US FAERS
278Blood creatinine abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
279Blood glucose decreasedFAERS: 2US FAERS
280Blood glucose increasedFAERS: 2US FAERS
281Blood sodium decreasedFAERS: 2US FAERS
282BradyphreniaFAERS: 2US FAERS
283Breast FeedingFAERS: 2US FAERS
284CalcinosisFAERS: 2US FAERS
285CandidiasisFAERS: 2US FAERS
286CataractFAERS: 2US FAERS
287Cerebral disorderFAERS: 2US FAERS
288Chronic Fatigue SyndromeFAERS: 2OFFSIDES
US FAERS
289DermatitisFAERS: 2US FAERS
290Diabetic foetopathyFAERS: 2US FAERS
291Disease prodromal stageFAERS: 2US FAERS
292Drug DependenceFAERS: 2US FAERS
293Drug abuseFAERS: 2US FAERS
294Drug screen false positiveFAERS: 2US FAERS
295Drug screen positiveFAERS: 2OFFSIDES
US FAERS
296DysgraphiaFAERS: 2US FAERS
297Electroencephalogram abnormalFAERS: 2US FAERS
298Emotional disorderFAERS: 2US FAERS
299EructationFAERS: 2US FAERS
300Facial PainFAERS: 2US FAERS
301Facial paralysisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
302Febrile NeutropeniaFAERS: 2OFFSIDES
US FAERS
303Feeling ColdFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
304Flank PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
305FlushingFAERS: 2US FAERS
306FractureFAERS: 2US FAERS
307Gastric ulcerFAERS: 2US FAERS
308GastroenteritisFAERS: 2OFFSIDES
US FAERS
309Genital burning sensationFAERS: 2US FAERS
310HemiplegiaFAERS: 2US FAERS
311HepatotoxicityFAERS: 2US FAERS
312HostilityFAERS: 2US FAERS
313HungerFAERS: 2US FAERS
314Hypoaesthesia facialFAERS: 2US FAERS
315HypokinesiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
316ImmobileFAERS: 2US FAERS
317Inappropriate schedule of product administrationFAERS: 2US FAERS
318Incorrect drug administration durationFAERS: 2US FAERS
319IndurationFAERS: 2US FAERS
320InfluenzaFAERS: 2US FAERS
321Intentional drug misuseFAERS: 2US FAERS
322Intestinal ObstructionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
323IridocyclitisFAERS: 2US FAERS
324Irritable Bowel SyndromeFAERS: 2US FAERS
325Labile blood pressureFAERS: 2US FAERS
326LeukocytosisFAERS: 2US FAERS
327LeukoencephalopathyFAERS: 2US FAERS
328Low birth weight babyFAERS: 2US FAERS
329Lyme DiseaseFAERS: 2US FAERS
330MenorrhagiaFAERS: 2US FAERS
331MicrocephalyFAERS: 2US FAERS
332Multiple MyelomaFAERS: 2OFFSIDES
US FAERS
333Multiple SclerosisFAERS: 2US FAERS
334Myocardial ruptureFAERS: 2US FAERS
335NephritisFAERS: 2US FAERS
336Nephrotic SyndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Neutrophil count decreasedFAERS: 2OFFSIDES
US FAERS
338Night sweatsFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
339Normal deliveryFAERS: 2US FAERS
340Pain of skinFAERS: 2US FAERS
341Pathological fractureFAERS: 2US FAERS
342Penile swellingFAERS: 2US FAERS
343Performance status decreasedFAERS: 2US FAERS
344PoisoningFAERS: 2US FAERS
345PolyneuropathyFAERS: 2OFFSIDES
US FAERS
346PolyuriaFAERS: 2US FAERS
347Pre-existing condition improvedFAERS: 2US FAERS
348PregnancyFAERS: 2US FAERS
349Product coating issueFAERS: 2US FAERS
350Product counterfeitFAERS: 2US FAERS
351Product formulation issueFAERS: 2US FAERS
352Product physical issueFAERS: 2US FAERS
353Product prescribing errorFAERS: 2US FAERS
354Product size issueFAERS: 2US FAERS
355Product taste abnormalFAERS: 2US FAERS
356Protein urine presentFAERS: 2US FAERS
357ProteinuriaFAERS: 2US FAERS
358PyelonephritisFAERS: 2US FAERS
359Reaction to drug excipientsFAERS: 2US FAERS
360Renal ColicFAERS: 2US FAERS
361Retinal DetachmentFAERS: 2US FAERS
362Retinal scarFAERS: 2US FAERS
363SchizophreniaFAERS: 2US FAERS
364Sexual DysfunctionFAERS: 2US FAERS
365Skin UlcerFAERS: 2US FAERS
366SluggishnessFAERS: 2US FAERS
367SneezingFAERS: 2US FAERS
368StuporFAERS: 216172845CTD
US FAERS
369Suicide attemptFAERS: 2US FAERS
370SunburnFAERS: 2US FAERS
371Symptom recurrenceFAERS: 2US FAERS
372Therapeutic response changedFAERS: 2US FAERS
373Therapy cessationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
374Throat irritationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
375Thrombotic strokeFAERS: 2US FAERS
376Tooth LossFAERS: 2US FAERS
377Urinary IncontinenceFAERS: 211197578CTD
US FAERS
378Vaginal mucosal blisteringFAERS: 2US FAERS
379Vascular calcificationFAERS: 2US FAERS
380Vascular purpuraFAERS: 2US FAERS
381VitritisFAERS: 2US FAERS
382Vulvovaginal burning sensationFAERS: 2US FAERS
383Wrong doseFAERS: 2US FAERS
384Wrong technique in drug usage processFAERS: 2US FAERS
385Abdominal AbscessFAERS: 1US FAERS
386Accidental underdoseFAERS: 1US FAERS
387Activities of daily living impairedFAERS: 1US FAERS
388AgeusiaFAERS: 1US FAERS
389Allergic reaction to excipientFAERS: 1US FAERS
390Allergy to chemicalsFAERS: 1US FAERS
391Alopecia AreataFAERS: 1US FAERS
392Altered visual depth perceptionFAERS: 1US FAERS
393Anal discomfortFAERS: 1US FAERS
394Anal inflammationFAERS: 1US FAERS
395Anorectal discomfortFAERS: 1US FAERS
396AnosmiaFAERS: 1US FAERS
397Anterior chamber inflammationFAERS: 1US FAERS
398Antinuclear antibody increasedFAERS: 1US FAERS
399Antiviral drug level above therapeuticFAERS: 1OFFSIDES
US FAERS
400ArthritisFAERS: 1US FAERS
401Arthropod biteFAERS: 1OFFSIDES
US FAERS
402Atrioventricular Septal DefectFAERS: 1US FAERS
403AuraFAERS: 1OFFSIDES
US FAERS
404Back disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
405BedriddenFAERS: 1US FAERS
406Bilirubin conjugated increasedFAERS: 1US FAERS
407BiopsyFAERS: 1US FAERS
408Bipolar DisorderFAERS: 119567772CTD
US FAERS
409Blighted ovumFAERS: 1US FAERS
410Blood HIV RNA below assay limitFAERS: 1US FAERS
411Blood albumin decreasedFAERS: 1OFFSIDES
US FAERS
412Blood alcohol increasedFAERS: 1US FAERS
413Blood blisterFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
414Blood creatine phosphokinase increasedFAERS: 1US FAERS
415Blood electrolytes abnormalFAERS: 1US FAERS
416Blood heavy metal increasedFAERS: 1US FAERS
417Blood immunoglobulin G increasedFAERS: 1US FAERS
418Blood iron decreasedFAERS: 1US FAERS
419Blood osmolarity increasedFAERS: 1US FAERS
420BradykinesiaFAERS: 1US FAERS
421Breakthrough PainFAERS: 1US FAERS
422Breech PresentationFAERS: 1US FAERS
423BronchiectasisFAERS: 1US FAERS
424BronchitisFAERS: 1US FAERS
425BronchospasmFAERS: 1US FAERS
426BruxismFAERS: 1US FAERS
427Cardiac ArrestFAERS: 1US FAERS
428Cardiac FlutterFAERS: 1US FAERS
429CatatoniaFAERS: 1US FAERS
430CellulitisFAERS: 1OFFSIDES
US FAERS
431Cerebral artery occlusionFAERS: 1US FAERS
432Cerebral atrophyFAERS: 1OFFSIDES
US FAERS
433Cerebral circulatory failureFAERS: 1US FAERS
434Cervical dysplasiaFAERS: 1US FAERS
435Cervix carcinomaFAERS: 1US FAERS
436ChemotherapyFAERS: 1US FAERS
437Chest wall painFAERS: 1US FAERS
438CholangitisFAERS: 1US FAERS
439ChorioretinitisFAERS: 1US FAERS
440Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
441Clostridium colitisFAERS: 1US FAERS
442Cold sweatFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
443Complement factor C3 decreasedFAERS: 1US FAERS
444Congenital cerebral cystFAERS: 1US FAERS
445Congenital cytomegalovirus infectionFAERS: 1US FAERS
446Congenital hepatobiliary anomalyFAERS: 1US FAERS
447Consciousness fluctuatingFAERS: 1US FAERS
448Crystal urine presentFAERS: 1US FAERS
449CystitisFAERS: 1US FAERS
450CytopeniaFAERS: 1US FAERS
451Dark circles under eyesFAERS: 1US FAERS
452Deafness NeurosensoryFAERS: 1OFFSIDES
US FAERS
453Dermatitis HerpetiformisFAERS: 1US FAERS
454Diabetes MellitusFAERS: 1US FAERS
455Diabetes mellitus inadequate controlFAERS: 1US FAERS
456Diabetic KetoacidosisFAERS: 1US FAERS
457DiaphragmalgiaFAERS: 1US FAERS
458DissociationFAERS: 1US FAERS
459DroolingFAERS: 1US FAERS
460Drug administered at inappropriate siteFAERS: 1US FAERS
461Drug effect delayedFAERS: 1US FAERS
462Drug effective for unapproved indicationFAERS: 1US FAERS
463Drug exposure before pregnancyFAERS: 1US FAERS
464Drug level above therapeuticFAERS: 1US FAERS
465Drug level decreasedFAERS: 1US FAERS
466Duodenal UlcerFAERS: 1US FAERS
467DysphemiaFAERS: 1US FAERS
468EcchymosisFAERS: 1US FAERS
469Economic problemFAERS: 1US FAERS
470Electrolyte imbalanceFAERS: 1US FAERS
471Elevated moodFAERS: 1US FAERS
472Emergency CareFAERS: 1US FAERS
473Endodontic procedureFAERS: 1OFFSIDES
US FAERS
474Enterococcal infectionFAERS: 1OFFSIDES
US FAERS
475EosinophiliaFAERS: 1US FAERS
476Epigastric discomfortFAERS: 1US FAERS
477Erectile dysfunctionFAERS: 1US FAERS
478ExcoriationFAERS: 1OFFSIDES
US FAERS
479Exposed bone in jawFAERS: 1US FAERS
480Exposure during breast feedingFAERS: 1US FAERS
481Exposure via breast milkFAERS: 1US FAERS
482Extremity contractureFAERS: 1US FAERS
483Eye InfectionFAERS: 1US FAERS
484Eyelid Function DisorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
485Facial NeuralgiaFAERS: 1US FAERS
486Facial ParesisFAERS: 1US FAERS
487False negative investigation resultFAERS: 1US FAERS
488False positive laboratory resultFAERS: 1US FAERS
489Fat redistributionFAERS: 1US FAERS
490Flat affectFAERS: 1US FAERS
491Food AllergyFAERS: 1US FAERS
492Foreign body sensation in eyesFAERS: 1US FAERS
493Foreign body traumaFAERS: 1US FAERS
494FormicationFAERS: 1OFFSIDES
US FAERS
495Genital dischargeFAERS: 1US FAERS
496Genital infectionFAERS: 1US FAERS
497Genital rashFAERS: 1OFFSIDES
US FAERS
498Gingival RecessionFAERS: 1US FAERS
499Gingival blisterFAERS: 1US FAERS
500GingivitisFAERS: 1US FAERS
501GlaucomaFAERS: 1US FAERS
502Granulomatous liver diseaseFAERS: 1US FAERS
503GranulomaFAERS: 1US FAERS
504HalitosisFAERS: 1US FAERS
505Hallucinations, mixedFAERS: 1US FAERS
506HemiparesisFAERS: 1OFFSIDES
US FAERS
507Hepatic calcificationFAERS: 1US FAERS
508Hepatitis BFAERS: 1US FAERS
509HepatosplenomegalyFAERS: 1US FAERS
510Herpes simplex serology negativeFAERS: 1US FAERS
511Herpes simplex test negativeFAERS: 1US FAERS
512Hormone level abnormalFAERS: 1US FAERS
513HydronephrosisFAERS: 1OFFSIDES
US FAERS
514HyperventilationFAERS: 1US FAERS
515HypocomplementaemiaFAERS: 1US FAERS
516HypotrichosisFAERS: 1US FAERS
517HysteroscopyFAERS: 1US FAERS
518IleusFAERS: 1US FAERS
519Impaired gastric emptyingFAERS: 1US FAERS
520ImpatienceFAERS: 1US FAERS
521ImpetigoFAERS: 1US FAERS
522Implant site reactionFAERS: 1US FAERS
523IncontinenceFAERS: 1US FAERS
524Incorrect route of drug administrationFAERS: 1US FAERS
525Initial insomniaFAERS: 1US FAERS
526Intrauterine infectionFAERS: 1US FAERS
527Joint injuryFAERS: 1US FAERS
528Joint prosthesis userFAERS: 1US FAERS
529LabyrinthitisFAERS: 1US FAERS
530LagophthalmosFAERS: 1US FAERS
531Laryngeal discomfortFAERS: 1US FAERS
532Limb operationFAERS: 1US FAERS
533LipoatrophyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
534LipomaFAERS: 1US FAERS
535Loss of personal independence in daily activitiesFAERS: 1US FAERS
536Lung AbscessFAERS: 1US FAERS
537Lupus-like syndromeFAERS: 1US FAERS
538LymphadenitisFAERS: 1US FAERS
539MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
540Macular fibrosisFAERS: 1US FAERS
541Manufacturing materials issueFAERS: 1US FAERS
542Mastication disorderFAERS: 1US FAERS
543Meconium ileusFAERS: 1US FAERS
544Meconium peritonitisFAERS: 1US FAERS
545MeibomianitisFAERS: 1US FAERS
546MeningiomaFAERS: 1US FAERS
547MicroalbuminuriaFAERS: 1US FAERS
548Middle insomniaFAERS: 1US FAERS
549Migraine with AuraFAERS: 1US FAERS
550MoaningFAERS: 1US FAERS
551Mononeuropathy MultiplexFAERS: 1US FAERS
552MonoplegiaFAERS: 1US FAERS
553Mucosal erosionFAERS: 1US FAERS
554Muscle FatigueFAERS: 1US FAERS
555Muscle RigidityFAERS: 1US FAERS
556Muscle SpasticityFAERS: 1US FAERS
557Muscle tightnessFAERS: 1US FAERS
558Musculoskeletal chest painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
559Narcissistic Personality DisorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
560Nasal discomfortFAERS: 1US FAERS
561Nasal mucosal disorderFAERS: 1US FAERS
562NephrectomyFAERS: 1US FAERS
563Nephrogenic Diabetes InsipidusFAERS: 1US FAERS
564Nerve injuryFAERS: 1US FAERS
565NeuropathyFAERS: 1US FAERS
566No adverse reactionFAERS: 1US FAERS
567NocturiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
568Non-proliferative retinopathyFAERS: 1US FAERS
569Normal pregnancyFAERS: 1US FAERS
570Obstructive nephropathyFAERS: 1US FAERS
571Ocular icterusFAERS: 1US FAERS
572OnychalgiaFAERS: 1US FAERS
573Open woundFAERS: 1OFFSIDES
US FAERS
574Opiates positiveFAERS: 1US FAERS
575OpisthotonusFAERS: 1US FAERS
576Oral candidiasisFAERS: 1US FAERS
577Oral mucosal eruptionFAERS: 1US FAERS
578Oral pruritusFAERS: 1US FAERS
579Oropharyngeal blisteringFAERS: 1US FAERS
580Oropharyngeal swellingFAERS: 1US FAERS
581Osteonecrosis of JawFAERS: 1US FAERS
582OsteopeniaFAERS: 1US FAERS
583Pancreatic enlargementFAERS: 1US FAERS
584PapuleFAERS: 1US FAERS
585ParaplegiaFAERS: 1US FAERS
586Partner stressFAERS: 1US FAERS
587Patent ductus arteriosusFAERS: 1US FAERS
588Pelvic PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
589PemphigusFAERS: 1US FAERS
590Peripancreatic fluid collectionFAERS: 1US FAERS
591PeritonsillitisFAERS: 1US FAERS
592Personality ChangeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
593PetechiaeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
594PharyngitisFAERS: 1US FAERS
595PhotodermatosisFAERS: 1US FAERS
596PiloerectionFAERS: 1US FAERS
597PleocytosisFAERS: 1OFFSIDES
US FAERS
598Pneumonia herpes viralFAERS: 1US FAERS
599PneumonitisFAERS: 1US FAERS
600Polymerase Chain ReactionFAERS: 1US FAERS
601Post-Traumatic Stress DisorderFAERS: 1US FAERS
602Postrenal failureFAERS: 1US FAERS
603Prescribed underdoseFAERS: 1US FAERS
604Product complaintFAERS: 1US FAERS
605Product difficult to swallowFAERS: 1US FAERS
606Product dose omissionFAERS: 1US FAERS
607Product label confusionFAERS: 1US FAERS
608Product preparation errorFAERS: 1US FAERS
609Product storage errorFAERS: 1US FAERS
610Product use complaintFAERS: 1US FAERS
611Protein total increasedFAERS: 1US FAERS
612Pruritus AniFAERS: 1US FAERS
613Pulmonary EmbolismFAERS: 1US FAERS
614Pulmonary FibrosisFAERS: 1US FAERS
615Pustular psoriasisFAERS: 1US FAERS
616QuadriplegiaFAERS: 1US FAERS
617Reaction to azo-dyesFAERS: 1US FAERS
618Rectal dischargeFAERS: 1US FAERS
619RegurgitationFAERS: 1US FAERS
620Rehabilitation therapyFAERS: 1US FAERS
621Respiratory FailureFAERS: 1OFFSIDES
US FAERS
622Respiratory tract infection viralFAERS: 1US FAERS
623Retinal Artery OcclusionFAERS: 1US FAERS
624Retinal depigmentationFAERS: 1US FAERS
625RetinitisFAERS: 1US FAERS
626Rheumatoid factor increasedFAERS: 1US FAERS
627RosaceaFAERS: 1US FAERS
628Saliva alteredFAERS: 1US FAERS
629ScabFAERS: 1US FAERS
630SciaticaFAERS: 1US FAERS
631Seizure like phenomenaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
632Senile dementiaFAERS: 1US FAERS
633Sensation of blood flowFAERS: 1US FAERS
634Sexual transmission of infectionFAERS: 1US FAERS
635Similar reaction on previous exposure to drugFAERS: 1US FAERS
636Sinus TachycardiaFAERS: 1US FAERS
637Sinus bradycardiaFAERS: 1US FAERS
638SinusitisFAERS: 1OFFSIDES
US FAERS
639Skin tightnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
640Somatosensory evoked potentials abnormalFAERS: 1US FAERS
641SoporFAERS: 1US FAERS
642Sperm count decreasedFAERS: 1US FAERS
643Spermatozoa abnormalFAERS: 1US FAERS
644SplenectomyFAERS: 1US FAERS
645SplenomegalyFAERS: 1US FAERS
646StaringFAERS: 1US FAERS
647StenosisFAERS: 1US FAERS
648Stool heavy metal positiveFAERS: 1US FAERS
649StrabismusFAERS: 1US FAERS
650Sudden infant death syndromeFAERS: 1US FAERS
651SuperinfectionFAERS: 1US FAERS
652Supraventricular tachycardiaFAERS: 1US FAERS
653Suture insertionFAERS: 1US FAERS
654Tablet issueFAERS: 1US FAERS
655Temperature intoleranceFAERS: 1US FAERS
656TetanyFAERS: 1US FAERS
657Thalamic infarctionFAERS: 1US FAERS
658Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
659Therapy regimen changedFAERS: 1US FAERS
660Thermal burnFAERS: 1US FAERS
661Tongue bitingFAERS: 1US FAERS
662Tongue discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
663Tongue eruptionFAERS: 1US FAERS
664ToothacheFAERS: 1US FAERS
665Transcription medication errorFAERS: 1US FAERS
666Trigeminal Nerve DisorderFAERS: 1US FAERS
667Trigeminal NeuralgiaFAERS: 1US FAERS
668Type III immune complex mediated reactionFAERS: 1US FAERS
669UlcerFAERS: 1US FAERS
670Umbilical herniaFAERS: 1US FAERS
671Unexpected therapeutic drug effectFAERS: 1US FAERS
672Urethritis noninfectiveFAERS: 1US FAERS
673Urinary hesitationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
674Urine output increasedFAERS: 1US FAERS
675Vaginal mycosisFAERS: 1US FAERS
676Varicella virus test positiveFAERS: 1US FAERS
677Venous InjuryFAERS: 1US FAERS
678Venous thrombosis limbFAERS: 1US FAERS
679Ventricular FibrillationFAERS: 1US FAERS
680Ventricular arrhythmiaFAERS: 1US FAERS
681Vertebral artery occlusionFAERS: 1US FAERS
682Visual disturbanceFAERS: 1US FAERS
683Vitamin D DeficiencyFAERS: 1US FAERS
684Vitreous floatersFAERS: 1US FAERS
685Vitreous opacitiesFAERS: 1US FAERS
686Vulvovaginal discomfortFAERS: 1US FAERS
687White blood cell count abnormalFAERS: 1US FAERS
688White matter lesionFAERS: 1US FAERS
689Wrong drug administeredFAERS: 1US FAERS
690cancer surgeryFAERS: 1US FAERS
691colonoscopyFAERS: 1US FAERS
692muscle injuryFAERS: 1US FAERS
693pH body fluid abnormalFAERS: 1US FAERS
694Abdominal tendernessCanada Vigilance: 1Canada Vigilance
695Abnormal cervical smearOFFSIDES
696AbuseOFFSIDES
697Actinic keratosisOFFSIDES
698Acute fatty liver of pregnancyOFFSIDES
699Acute graft versus host disease in liverOFFSIDES
700AgraphiaOFFSIDES
701Albumin globulin ratio decreasedOFFSIDES
702Alcohol interactionCanada Vigilance: 1Canada Vigilance
703Allergy to arthropod stingOFFSIDES
704Altered bowel functionOFFSIDES
705AlveoloplastyOFFSIDES
706Amaurosis FugaxOFFSIDES
707Amylase increasedCanada Vigilance: 1Canada Vigilance
708AngiolipomaOFFSIDES
709AnhedoniaOFFSIDES
710AnhidrosisOFFSIDES
711Anorectal cellulitisOFFSIDES
712Antiphospholipid SyndromeOFFSIDES
713Antiphospholipid antibodies positiveOFFSIDES
714ApathyOFFSIDES
715Apparent deathOFFSIDES
716ArthropathyOFFSIDES
717Aseptic MeningitisOFFSIDES
718Autoimmune inner ear diseaseOFFSIDES
719AutomatismOFFSIDES
720Bacterial disease carrierOFFSIDES
721Bacterial sepsisOFFSIDES
722Basal cell carcinomaOFFSIDES
723Biliary DyskinesiaOFFSIDES
724Biopsy bone marrow abnormalOFFSIDES
725Blood bicarbonateOFFSIDES
726Blood cholinesterase decreasedOFFSIDES
727Blood creatine phosphokinase decreasedOFFSIDES
728Blood electrolytes decreasedOFFSIDES
729Blood insulin decreasedOFFSIDES
730Blood lactate dehydrogenase abnormalOFFSIDES
731Blood parathyroid hormone decreasedOFFSIDES
732Blood phosphorusOFFSIDES
733Blood sodiumOFFSIDES
734Blood uric acidOFFSIDES
735Blurred visionOFFSIDES
736Bone lesionOFFSIDES
737Bone scan abnormalOFFSIDES
738Bone swellingOFFSIDES
739Bone trimmingOFFSIDES
740Breast CystOFFSIDES
741BronchopneumoniaOFFSIDES
742BursitisOFFSIDES
743CD4 Lymphocytes DecreasedOFFSIDES
744Cardiovascular insufficiencyOFFSIDES
745Catheter site erythemaOFFSIDES
746Cerebellar AtaxiaOFFSIDES
747Cerebral artery stenosisOFFSIDES
748Cervicobrachial syndromeOFFSIDES
749Chemotherapeutic drug level increasedOFFSIDES
750ChondromalaciaOFFSIDES
751Chorea11440337CTD
752Chronic Obstructive Airway DiseaseOFFSIDES
753Chronic sinusitisOFFSIDES
754CirrhosisOFFSIDES
755ConfabulationOFFSIDES
756Confusion11197578CTD
757Consciousness Disorders19187258CTD
758CrystalluriaCanada Vigilance: 1Canada Vigilance
759Culture positiveOFFSIDES
760Cyclothymic DisorderOFFSIDES
761Cystitis-like symptomOFFSIDES
762CystOFFSIDES
763Cytomegalovirus test positiveOFFSIDES
764DebridementOFFSIDES
765Decreased LibidoOFFSIDES
766DemyelinationOFFSIDES
767Dental abscessOFFSIDES
768Dental cariesOFFSIDES
769Dental prosthesis userOFFSIDES
770Denture wearerOFFSIDES
771Device breakageOFFSIDES
772DiabetesOFFSIDES
773Diarrhea18156240CTD
OFFSIDES
774DiverticulumOFFSIDES
775DrowsinessOFFSIDES
776Drug addictOFFSIDES
777Drug withdrawal headacheOFFSIDES
778DyschromatopsiaCanada Vigilance: 1Canada Vigilance
779DyspareuniaOFFSIDES
780Ear discomfortOFFSIDES
781EmbolismOFFSIDES
782EnterocolitisOFFSIDES
783Erythema InfectiosumOFFSIDES
784ExophthalmosOFFSIDES
785FibrosarcomaOFFSIDES
786Fistula dischargeOFFSIDES
787Gaze palsyOFFSIDES
788Genital swellingCanada Vigilance: 1Canada Vigilance
789Gestational DiabetesOFFSIDES
790Glioblastoma MultiformeOFFSIDES
791Graft infectionOFFSIDES
792GranulocytosisOFFSIDES
793Hallucinations18156240
19187258
21187705
CTD
794Hepatic artery thrombosisOFFSIDES
795Hepatitis B VirusOFFSIDES
796Hepatitis B positiveOFFSIDES
797Herpes Labialis17668537CTD
798High frequency ablationOFFSIDES
799Histiocytosis haematophagicOFFSIDES
800Human herpesvirus 8 infectionOFFSIDES
801HypomaniaOFFSIDES
802ImmunosuppressionOFFSIDES
803Incision site infectionOFFSIDES
804Infusion site mobility decreasedOFFSIDES
805Interleukin level increasedOFFSIDES
806Intervertebral Disc DegenerationOFFSIDES
807Intervertebral disc disorderOFFSIDES
808JC virus infectionOFFSIDES
809Joint InstabilityOFFSIDES
810Joint Range of Motion DecreasedOFFSIDES
811Joint sprainOFFSIDES
812Keratitis siccaOFFSIDES
813Kidney FailureOFFSIDES
814Left Ventricular HypertrophyOFFSIDES
815Leukopenia neonatalOFFSIDES
816Life expectancy shortenedOFFSIDES
817Lipase increasedCanada Vigilance: 1Canada Vigilance
818Loose toothOFFSIDES
819LymphohistiocytosisOFFSIDES
820Mallory-Weiss SyndromeOFFSIDES
821Mass excisionOFFSIDES
822MastectomyOFFSIDES
823Mechanical urticariaOFFSIDES
824Metastatic NeoplasmOFFSIDES
825MetatarsalgiaOFFSIDES
826Monoclonal immunoglobulin presentOFFSIDES
827MononeuritisOFFSIDES
828Mononeuropathies15159513CTD
829Multiple allergiesOFFSIDES
830Muscle WeaknessOFFSIDES
831Musculoskeletal discomfortOFFSIDES
832MyelocytosisOFFSIDES
833Myeloma recurrenceOFFSIDES
834MyofascitisOFFSIDES
835Nasal sinus drainageOFFSIDES
836Nerve BlockOFFSIDES
837Neurotoxicity Syndromes

View details

CTD
838Nodule on extremityOFFSIDES
839NoduleOFFSIDES
840NystagmusOFFSIDES
841OsteomyelitisOFFSIDES
842OsteoporosisOFFSIDES
843Panic DisorderOFFSIDES
844PanniculitisOFFSIDES
845ParaparesisOFFSIDES
846PeriodontitisOFFSIDES
847Perivascular dermatitisOFFSIDES
848Pituitary enlargementOFFSIDES
849PlasmacytomaOFFSIDES
850PleurectomyOFFSIDES
851Positron emission tomogram abnormalOFFSIDES
852Postmenopausal bleedingOFFSIDES
853Proctitis herpesOFFSIDES
854Productive CoughCanada Vigilance: 1Canada Vigilance
OFFSIDES
855Prothrombin level decreasedOFFSIDES
856Prothrombin time abnormalOFFSIDES
857Pulmonary arterial pressure increasedOFFSIDES
858Quality of life decreasedOFFSIDES
859Radicular painOFFSIDES
860Refusal of treatment by relativeOFFSIDES
861Residual urineOFFSIDES
862RhinitisOFFSIDES
863SacroiliitisOFFSIDES
864ScotomaOFFSIDES
865Sebaceous hyperplasiaOFFSIDES
866Seizures14632595
14632597
CTD
867Seroconversion test positiveOFFSIDES
868SigmoiditisOFFSIDES
869Skin IndurationOFFSIDES
870Skin hypertrophyOFFSIDES
871Spinal column stenosisOFFSIDES
872SpondylolisthesisOFFSIDES
873Stem cell transplantOFFSIDES
874Stenotrophomonas infectionOFFSIDES
875Submandibular massOFFSIDES
876Suppressed lactationCanada Vigilance: 1Canada Vigilance
877TachyphreniaCanada Vigilance: 1Canada Vigilance
878TendinitisOFFSIDES
879Therapeutic procedureOFFSIDES
880Therapy non-responderOFFSIDES
881Thoracic Outlet SyndromeOFFSIDES
882ThrombophlebitisOFFSIDES
883Thrombosed varicose veinOFFSIDES
884Tooth ExtractionOFFSIDES
885Tooth repairOFFSIDES
886ToxoplasmosisOFFSIDES
887TracheobronchitisOFFSIDES
888Transaminases increasedOFFSIDES
889Urinary tract infection staphylococcalOFFSIDES
890Urine nitrogenOFFSIDES
891Uterine CancerOFFSIDES
892Uterine PerforationOFFSIDES
893Varicose vein operationOFFSIDES
894Venoocclusive diseaseOFFSIDES
895Venous InsufficiencyOFFSIDES
896Vertebrobasilar InsufficiencyOFFSIDES
897Viral pharyngitisOFFSIDES
898Visual brightnessOFFSIDES
899Walking aid userOFFSIDES
900Weight GainOFFSIDES
901Wheelchair userOFFSIDES
902Wound dehiscenceOFFSIDES
903Wound infection staphylococcalOFFSIDES
904YawningOFFSIDES
905prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.